Pre-Open Stock Movers 1/21: (LLNW) (PTON) (UAA) Higher; (NFLX) (RIOT) (MARA) Lower (more...) Jan 21, 2022 09:17AM
Regulus Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference Apr 7, 2021 08:07AM
Regulus to Present at the Needham Healthcare Conference Mar 20, 2018 04:15PM
Regulus Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares Jul 25, 2017 04:05PM
Regulus Therapeutics (RGLS) Announces 44M Share Common Offering Jul 20, 2017 05:52AM


Jul 19, 2017 09:45PM Regulus Announces Pricing of Public Offering of Common Stock
Mar 28, 2017 08:30AM Regulus to Present at the 16th Annual Needham Healthcare Conference
Jan 30, 2017 07:28AM Needham & Company Downgrades Regulus Therapeutics (RGLS) to Hold
Jun 28, 2016 07:26AM Regulus Therapeutics (RGLS): Cutting PT to $10 - Needham & Company
Jun 7, 2016 12:09PM Streetinsider.com's Hot Lunchtime Reads 6/7: (BIIB) (YHOO) (VRX) (RGLS) (TSLA)
Jun 7, 2016 11:59AM Needham & Company Affirms Regulus Therapeutics (RGLS) at 'Buy'; Says Role of RG-101 in HCV Remains Unclear
Feb 17, 2016 11:38AM Needham & Company Reiterates Bullish View on Regulus Therapeutics (RGLS) Following Latest Data
Nov 24, 2014 10:33AM Notable Analyst Rating Changes 11/24: (SCTY) (LL) (KATE) Upgraded; (CBI) (VZ) (XOM) Downgraded
Nov 24, 2014 09:31AM Pre-Open Stock Movers 11/24: (RNA) (CIMT) (PTP) Higher; (LGF) (TSL) (CBI) Lower (more...)
Oct 29, 2014 06:50AM Regulus Therapeutics (RGLS) 5.29M Offering Prices at $17/Share
Oct 27, 2014 04:01PM Regulus Therapeutics (RGLS) Reports $80M Common Stock Offering
Oct 27, 2014 04:00PM Regulus Therapeutics (RGLS) Announces $80M Common Stock Offering
Oct 22, 2014 12:26PM Regulus Therapeutics (RGLS) PT Lifted to $18 at Needham & Company on Surprisingly Strong RG-101 Data in HCV
May 9, 2014 07:06AM Regulus Therapeutics (RGLS) Bullish Stance Reiterated at Needham & Company Post Q1
Feb 28, 2014 07:58AM Regulus Therapeutics (RGLS) Target Raised to $14 at Needham & Company
Jul 17, 2013 08:01AM Regulus Therapeutics (RGLS) Prices 4.5M Shares at $9.50
May 15, 2013 07:54AM Regulus Therapeutics (NASDAQ: RGLS) Clinical Candidate in HCV Nominated; Reiterate Buy - Needham & Company
Nov 5, 2012 07:58AM Needham & Company Starts Regulus Therapeutics (RGLS) at Buy
Oct 4, 2012 04:09PM Regulus Therapeutics (RGLS) IPO Closes 5% Higher